MEK Inhibitor News and Research

RSS
MEK inhibition could limit T cell exhaustion and give a boost to immunotherapy

MEK inhibition could limit T cell exhaustion and give a boost to immunotherapy

Tailored drug combinations improve outcomes for treatment-resistant advanced melanoma

Tailored drug combinations improve outcomes for treatment-resistant advanced melanoma

Researchers uncover possible cause of pain in neurofibromatosis type 1

Researchers uncover possible cause of pain in neurofibromatosis type 1

Targeted therapy treats mixed histiocytosis following multiple skull relapses

Targeted therapy treats mixed histiocytosis following multiple skull relapses

Blocking collagen signaling improves the delivery of macromolecular drugs in pancreatic cancer

Blocking collagen signaling improves the delivery of macromolecular drugs in pancreatic cancer

Nanodroplet array revolutionizes search for new drugs

Nanodroplet array revolutionizes search for new drugs

Long noncoding RNA ESSENCE identified as key driver of colorectal cancer progression

Long noncoding RNA ESSENCE identified as key driver of colorectal cancer progression

Dana-Farber experts present innovative cancer studies at the 2025 AACR Annual Meeting

Dana-Farber experts present innovative cancer studies at the 2025 AACR Annual Meeting

Trametinib shows promise in treating severe hypertrophic cardiomyopathy in children

Trametinib shows promise in treating severe hypertrophic cardiomyopathy in children

Researchers demonstrate a new method to combat pancreatic cancer

Researchers demonstrate a new method to combat pancreatic cancer

New dual kinase inhibitor MTX-531 shows promise in overcoming cancer therapy resistance

New dual kinase inhibitor MTX-531 shows promise in overcoming cancer therapy resistance

Causal variant-targeted ribonucleic acid treatment for congenital melanocytic nevi

Causal variant-targeted ribonucleic acid treatment for congenital melanocytic nevi

MEK inhibitor trametinib shows potential in pediatric JMML treatment

MEK inhibitor trametinib shows potential in pediatric JMML treatment

Advancing therapeutic insights: The impact of understanding cellular target engagement with NanoBRET® technology

Advancing therapeutic insights: The impact of understanding cellular target engagement with NanoBRET® technology

Breakthrough study reveals melanoma's resistance tactics to targeted therapy

Breakthrough study reveals melanoma's resistance tactics to targeted therapy

Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC

Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC

Study uncovers cell signaling pathway that regulates melanoma brain metastasis

Study uncovers cell signaling pathway that regulates melanoma brain metastasis

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

Non-traditional gene fusions in luminal breast cancer: A new target for therapy

Non-traditional gene fusions in luminal breast cancer: A new target for therapy

New precision medicine trial shows promise for treating rare brain tumors

New precision medicine trial shows promise for treating rare brain tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.